- Home
- CELU vs ATTT Comparison
CELU vs ATTT Comparison
Compare CELU & ATTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.35
N/A
Current Price
$2.60
Company Overview
Basic Information| Metric | CELU | ATTT |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3M | 17.4M |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CELU | ATTT |
|---|---|---|
| Price | $1.35 | $2.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 178.9K | 15.0K |
| Earning Date | 09-29-2026 | 08-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $26,550,000.00 | N/A |
| Revenue This Year | $165.42 | N/A |
| Revenue Next Year | $305.36 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.56 | $2.51 |
| 52 Week High | $2.55 | $2.97 |
Technical Indicators
Market Signals| Indicator | CELU | ATTT |
|---|---|---|
| Relative Strength Index (RSI) | 51.58 | N/A |
| Support Level | $1.11 | $2.51 |
| Resistance Level | $1.43 | N/A |
| Average True Range (ATR) | 0.11 | 0.14 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 57.58 | 19.57 |
Price Performance
Historical Comparison CELU
ATTT
About CELU Celularity Inc.
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.